RENAL FAILURE IS REVERSIBLE AFTER THERAPY WITH BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA

被引：0
|
作者：
Goranova-Marinova, V. [1 ]
Nedeva, A. [2 ]
Nikolov, I. [2 ]
Georgiev, P. [1 ]
Hristova, I. [1 ]
Gigov, I. [2 ]
Raynov, J. [2 ]
Goranov, S. [1 ]
机构：
[1] Univ Hosp Sv Georgi, Clin Hematol, Plovdiv, Bulgaria
[2] Mil Med Acad, Dept Hematol & Oncol, Sofia, Bulgaria
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1508
引用
收藏
页码：602 / 603
页数：2
相关论文
共 50 条
  • [41] Bortezomib for the treatment of multiple myeloma patients
    Green, C.
    Bryant, J.
    Takeda, A.
    Cooper, K.
    Clegg, A.
    Smith, A.
    Stephens, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 29 - 33
  • [42] COMBINATION THERAPY BASED ON BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Cai, C.
    He, J.
    Yang, Y.
    Han, H.
    Zheng, G.
    Zheng, W.
    Wei, W.
    Wu, W.
    Ye, Y.
    Shi, S.
    Xie, X.
    Li, L.
    Zhang, Z.
    Huang, H.
    Huang, H.
    Zhen, Z.
    HAEMATOLOGICA, 2012, 97 : 611 - 611
  • [43] Superior myeloma response with bortezomib-based regimen in multiple myeloma patients with renal impairment
    Bao, Li
    Lu, Jin
    Wang, Shihua
    Huang, Xiaojun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 6200 - 6209
  • [44] Bortezomib, thalidomide, and dexamethasone as induction therapy for patients with symptomatic multiple myeloma
    Kaufman, Jonathan L.
    Gleason, Charise
    Heffner, Leonard
    Lonial, Sagar
    BLOOD, 2007, 110 (11) : 1055A - 1055A
  • [45] Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma
    Maekawa, Keiko
    Ri, Masaki
    Nakajima, Miki
    Sekine, Akihiro
    Ueda, Ryuzo
    Tohkin, Masahiro
    Miyata, Naoki
    Saito, Yoshiro
    Iida, Shinsuke
    CANCER SCIENCE, 2019, 110 (10) : 3267 - 3274
  • [46] Severe acute renal failure asa result oftumor lysis syndromeafter bortezomib therapy in a case of therapy-resistant multiple myeloma
    Stankovic, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 544 - 544
  • [47] Ocular Complications of Bortezomib Therapy in Multiple Myeloma
    Puri, Sonam
    Joshi, Jitesh
    Derman, Olga
    Kornblum, Noah
    Verma, Amit
    Braunschweig, Ira
    Battini, Ramakrishna
    BLOOD, 2014, 124 (21)
  • [48] Chalazia Associated with Bortezomib Therapy for Multiple Myeloma
    Grob, Seanna R.
    Jakobiec, Frederick A.
    Rashid, Alia
    Yoon, Michael K.
    OPHTHALMOLOGY, 2014, 121 (09) : 1845 - 1847
  • [49] What is the survival of patients with relapsed multiple myeloma after IMiDs and bortezomib?
    Macro, Margaret
    HEMATOLOGIE, 2012, 18 (02): : 92 - 93
  • [50] Evolving Treatments in Multiple Myeloma Patients with Renal Failure
    Gozzetti, Alessandro
    Papini, Giulia
    Candi, Veronica
    Bocchia, Monica
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (04) : 276 - 279
12345